The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ACCELERATE DIAGNOSTICS INC NOTE 2.500% 3/1 00430HAB8 1,828 2,600,000 PRN   SOLE   2,600,000 0 0
ASPEN AEROGELS INC COM 04523Y105 16,104 350,000 SH   SOLE   350,000 0 0
COMSCORE INC COM 20564W105 8,015 2,055,000 SH   SOLE   2,055,000 0 0
DIGIMARC CORP NEW COM 25381B101 861 25,000 SH   SOLE   25,000 0 0
EXAGEN INC COM 30068X103 4,012 295,000 SH   SOLE   295,000 0 0
FRANCHISE GROUP INC COM 35180X105 2,125 60,000 SH   SOLE   60,000 0 0
GAN LTD SHS G3728V109 4,387 295,000 SH   SOLE   295,000 0 0
GTY TECHNOLOGY HOLDINGS INC COM 362409104 8,648 1,150,000 SH   SOLE   1,150,000 0 0
HTG MOLECULAR DIAGNOSTICS IN COM NEW 40434H203 3,769 660,000 SH   SOLE   660,000 0 0
INSPIRED ENTMT INC COM 45782N108 3,335 285,000 SH   SOLE   285,000 0 0
ITERIS INC NEW COM 46564T107 7,524 1,425,000 SH   SOLE   1,425,000 0 0
NEPHROS INC COM 640671400 4,824 550,000 SH   SOLE   550,000 0 0
PDF SOLUTIONS INC COM 693282105 32,256 1,400,000 SH   SOLE   1,400,000 0 0
QUOTIENT TECHNOLOGY INC COM 749119103 9,603 1,650,000 SH   SOLE   1,650,000 0 0
RECRO PHARMA INC COM 75629F109 6,705 3,255,000 SH   SOLE   3,255,000 0 0
RESEARCH SOLUTIONS INC COM 761025105 2,346 900,000 SH   SOLE   900,000 0 0
THRYV HLDGS INC COM NEW 886029206 5,798 193,000 SH   SOLE   193,000 0 0
TRANSACT TECHNOLOGIES INC COM 892918103 1,807 130,000 SH   SOLE   130,000 0 0
VONAGE HLDGS CORP COM 92886T201 12,251 760,000 SH   SOLE   760,000 0 0